PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
238.00 - 242.07
140.53 - 242.25
26.77M / 38.44M (Avg.)
25.64 | 9.39
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
1.60%
Revenue growth of 1.60% while BIDU is flat. Bruce Berkowitz would check if a small edge can widen further.
2.64%
Gross profit growth of 2.64% while BIDU is zero. Bruce Berkowitz would see if minimal improvements could expand further.
-23.00%
Negative EBIT growth while BIDU is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-23.00%
Negative operating income growth while BIDU is at 0.00%. Joel Greenblatt would press for urgent turnaround measures.
-29.30%
Negative net income growth while BIDU stands at 0.00%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-30.00%
Negative EPS growth while BIDU is at 0.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-30.00%
Negative diluted EPS growth while BIDU is at 0.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.49%
Share change of 0.49% while BIDU is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
0.26%
Diluted share change of 0.26% while BIDU is zero. Bruce Berkowitz might see a minor difference that could widen over time.
No Data
No Data available this quarter, please select a different quarter.
-10.04%
Negative OCF growth while BIDU is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
132.62%
FCF growth of 132.62% while BIDU is zero. Bruce Berkowitz would see if modest improvements in free cash can accelerate further.
13901.55%
10Y revenue/share CAGR above 1.5x BIDU's 6921.46%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
246.97%
5Y revenue/share CAGR under 50% of BIDU's 1598.81%. Michael Burry would suspect a significant competitive gap or product weakness.
61.03%
3Y revenue/share CAGR under 50% of BIDU's 315.74%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
250.71%
OCF/share CAGR of 250.71% while BIDU is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
73.60%
3Y OCF/share CAGR of 73.60% while BIDU is zero. Bruce Berkowitz might see if small gains can expand into a broader advantage.
15313.14%
Similar net income/share CAGR to BIDU's 14203.41%. Walter Schloss would see parallel tailwinds or expansions for both firms.
176.83%
Below 50% of BIDU's 2771.99%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
33.97%
Below 50% of BIDU's 615.81%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
No Data
No Data available this quarter, please select a different quarter.
334.91%
Below 50% of BIDU's 754.95%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
95.48%
Below 50% of BIDU's 328.36%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-3.68%
Firm’s AR is declining while BIDU shows 0.00%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
23.55%
Inventory growth of 23.55% while BIDU is zero. Bruce Berkowitz wonders if we anticipate a new wave of demand or risk being stuck with extra product.
3.65%
Asset growth of 3.65% while BIDU is zero. Bruce Berkowitz checks if modest expansions can create a longer-term lead.
5.12%
BV/share growth of 5.12% while BIDU is zero. Bruce Berkowitz sees if small growth can compound into a strong advantage.
-7.19%
We’re deleveraging while BIDU stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
16.65%
R&D growth of 16.65% while BIDU is zero. Bruce Berkowitz checks if the moderate investment leads to meaningful product differentiation.
10.68%
SG&A growth of 10.68% while BIDU is zero. Bruce Berkowitz sees more spend on admin or marketing, expecting stronger top-line in return.